Kathleen Meeke

663 total citations
8 papers, 516 citations indexed

About

Kathleen Meeke is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Kathleen Meeke has authored 8 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Kathleen Meeke's work include Estrogen and related hormone effects (7 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (2 papers). Kathleen Meeke is often cited by papers focused on Estrogen and related hormone effects (7 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (2 papers). Kathleen Meeke collaborates with scholars based in United States and United Kingdom. Kathleen Meeke's co-authors include Clodia Osipo, V. Craig Jordan, Joan S. Lewis, Eric A. Ross, Eric L. Bell, Tianyu Li, Navdeep S. Chandel, Anthony G. Clementz, John R. Roberts and Kinnari Pandya and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kathleen Meeke

8 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathleen Meeke United States	8	275	266	250	92	49	8	516
Helen R. Kim United States	9	199 0.7×	213 0.8×	162 0.6×	85 0.9×	43 0.9×	9	420
Carol M. Dutkowski United Kingdom	9	188 0.7×	329 1.2×	287 1.1×	86 0.9×	35 0.7×	14	544
Jessy Abraham United States	13	243 0.9×	323 1.2×	204 0.8×	165 1.8×	34 0.7×	25	599
Annabell S. Oh United States	12	325 1.2×	395 1.5×	277 1.1×	118 1.3×	55 1.1×	13	615
Lianguo Kang United States	6	328 1.2×	250 0.9×	207 0.8×	56 0.6×	67 1.4×	7	521
Lanfang Qin United States	8	152 0.6×	301 1.1×	235 0.9×	108 1.2×	40 0.8×	14	528
Edmund C. Chang United States	6	469 1.7×	378 1.4×	218 0.9×	80 0.9×	49 1.0×	6	716
Richard Y. Lee United States	6	253 0.9×	394 1.5×	188 0.8×	160 1.7×	21 0.4×	6	614
A E Hornby United States	7	265 1.0×	304 1.1×	145 0.6×	62 0.7×	67 1.4×	7	540
Alicia Parkes United Kingdom	5	464 1.7×	332 1.2×	312 1.2×	145 1.6×	38 0.8×	10	641

Countries citing papers authored by Kathleen Meeke

Since Specialization

Citations

This map shows the geographic impact of Kathleen Meeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Meeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Meeke more than expected).

Fields of papers citing papers by Kathleen Meeke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Meeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Meeke. The network helps show where Kathleen Meeke may publish in the future.

Co-authorship network of co-authors of Kathleen Meeke

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Meeke. A scholar is included among the top collaborators of Kathleen Meeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Meeke. Kathleen Meeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Pandya, Kinnari, Kathleen Meeke, Anthony G. Clementz, et al.. (2011). Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. British Journal of Cancer. 105(6). 796–806. 110 indexed citations

2.

Kelly, Jeremiah F., Julia L. Bienias, Avni Shah, et al.. (2008). Levels of Estrogen Receptors α and β in Frontal Cortex of Patients with Alzheimers Disease: Relationship to Mini-Mental State Examination Scores. Current Alzheimer Research. 5(1). 45–51. 33 indexed citations

3.

Osipo, Clodia, Kathleen Meeke, Dong Cheng, et al.. (2007). Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.. PubMed. 30(2). 509–20. 29 indexed citations

4.

O’Regan, Ruth, Clodia Osipo, Eric A. Ariazi, et al.. (2006). Development and Therapeutic Options for the Treatment of Raloxifene-Stimulated Breast Cancer in Athymic Mice. Clinical Cancer Research. 12(7). 2255–2263. 26 indexed citations

5.

Lewis, Joan S., Clodia Osipo, Kathleen Meeke, & V. Craig Jordan. (2005). Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal. The Journal of Steroid Biochemistry and Molecular Biology. 94(1-3). 131–141. 95 indexed citations

6.

Lewis, Joan S., Kathleen Meeke, Clodia Osipo, et al.. (2005). Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen Deprivation. JNCI Journal of the National Cancer Institute. 97(23). 1746–1759. 193 indexed citations

7.

Osipo, Clodia, Kathleen Meeke, Hong Liu, et al.. (2005). Trastuzumab Therapy for Tamoxifen-Stimulated Endometrial Cancer. Cancer Research. 65(18). 8504–8513. 11 indexed citations

8.

Osipo, Clodia, Hong Liu, Kathleen Meeke, & V. Craig Jordan. (2004). The Consequences of Exhaustive Antiestrogen Therapy in Breast Cancer: Estrogen-Induced Tumor Cell Death. Experimental Biology and Medicine. 229(8). 722–731. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact